Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
204M
-
Shares change
-
-6.28M
-
Total reported value, excl. options
-
$3.5B
-
Value change
-
-$114M
-
Put/Call ratio
-
0.49
-
Number of buys
-
183
-
Number of sells
-
-156
-
Price
-
$17.15
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q4 2024
382 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q4 2024.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 204M shares
of 237M outstanding shares and own 86.03% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (38.1M shares), VANGUARD GROUP INC (18.2M shares), STATE STREET CORP (14.9M shares), Invesco Ltd. (11.3M shares), MORGAN STANLEY (5.53M shares), GEODE CAPITAL MANAGEMENT, LLC (5.43M shares), DIMENSIONAL FUND ADVISORS LP (4.67M shares), Nuveen Asset Management, LLC (4.55M shares), DEUTSCHE BANK AG\ (3.88M shares), and AMERICAN CENTURY COMPANIES INC (3.77M shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.